» Articles » PMID: 2392159

Antiarrhythmic Effects of a Benzothiazine Derivative (SD-3211) and Its Stereoisomer (SA3212) in Anaesthetized Rats and Isolated Perfused Rat Hearts Compared with Bepridil

Overview
Specialty Pharmacology
Date 1990 Jun 1
PMID 2392159
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The antiarrhythmic effects of a new calcium channel blocking agent (SD-3211) and its stereoisomer with additional sodium channel blocking activity (SA3212), were compared with those of a known antiarrhythmic drug (bepridil), using the left coronary artery ligation- and reperfusion-associated arrhythmia models both in isolated rat hearts and in anaesthetized rats. Isolated and perfused rat hearts were subjected to regional ischaemia for 15 min and subsequent reperfusion for 5 min. SD-3211 and SA3212 showed dose-dependently prolongations of the time interval between coronary ligation and first appearance of ventricular premature beats, reductions in the number of total ventricular premature beats during the ligation period and reductions in the incidence of reperfusion-induced ventricular fibrillation. The values of the negative logarithm of IC50 (mol/l) of SD-3211, SA3212 and bepridil were 7.97, 7.41 and 6.64 for the reduction of ventricular premature beats during ligation and 6.43, 7.49 and 6.17 for the reduction of ventricular fibrillation during reperfusion, respectively. In a separate study on force of concentration and coronary flow in perfused heart paced at 340-360 beats/min SD-3211 caused a significant negative inotropic effect between 10(-7) and 10(-6) mol/l. SA3212 at the concentration of less than 10(-6) mol/l did not result in any significant change in force of contraction. The coronary flow was increased dose-dependently by SA3212, while it was first increased and then reduced in the presence of higher concentration of SD-3211 (greater than 10(-7) mol/l). Hearts of anesthetized rats were also subjected to regional ischaemia for 7 min and subsequent reperfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

SD3212, a new antiarrhythmic drug, raises atrial fibrillation threshold in isolated rabbit hearts.

Matsuo R, Shirayama T, Inoue K, Matoba Y, Imai H, Shiraishi H Heart Vessels. 2000; 14(3):127-36.

PMID: 10776805 DOI: 10.1007/BF02482296.


SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells.

Hara Y, Nakaya H Br J Pharmacol. 1995; 116(6):2750-6.

PMID: 8591000 PMC: 1909141. DOI: 10.1111/j.1476-5381.1995.tb17237.x.


Electrophysiological effects of SD-3212, a new antiarrhythmic agent with vasodilator action, on guinea-pig ventricular cells.

Kodama I, Suzuki R, Maruyama K, TOYAMA J Br J Pharmacol. 1995; 114(2):503-9.

PMID: 7881749 PMC: 1510254. DOI: 10.1111/j.1476-5381.1995.tb13255.x.


Photochemically induced thrombosis of the rat coronary artery and functional evaluation of thrombus formation by occurrence of ventricular arrhythmias. Effects of acetylsalicylic acid and a thromboxane A2 synthetase inhibitor of thrombus formation.

Fukuchi M, Uematsu T, Araki S, Nakashima M Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(5):550-4.

PMID: 1470226 DOI: 10.1007/BF00169012.


Antiarrhythmic and electrophysiological effects of SD-3212, a novel Na+ and Ca++ channel blocker, in anaesthetized dogs with myocardial infarction in comparison with its stereoisomer (SD-3211) and bepridil.

Nagashima S, Uematsu T, Araki S, Matsuzaki T, Fukuchi M, Hashimoto H Naunyn Schmiedebergs Arch Pharmacol. 1992; 345(6):688-95.

PMID: 1321957 DOI: 10.1007/BF00164584.

References
1.
Miyawaki N, Furuta T, SHIGEI T, Yamauchi H, ISO T . Electrophysiological properties of SD-3211, a novel putative Ca2+ antagonist, in isolated guinea pig and rabbit hearts. J Cardiovasc Pharmacol. 1990; 16(5):769-75. DOI: 10.1097/00005344-199011000-00012. View

2.
Uematsu T, Cook N, Hof R, Vozeh S, Follath F . Effects of the enantiomers of the dihydropyridine derivative 202-791 on contractility, coronary flow and ischemia-related arrhythmias in rat heart. Eur J Pharmacol. 1986; 123(3):455-8. DOI: 10.1016/0014-2999(86)90723-5. View

3.
Coker S, Parratt J, LEDINGHAM I, Zeitlin I . Evidence that thromboxane contributes to ventricular fibrillation induced by reperfusion of the ischaemic myocardium. J Mol Cell Cardiol. 1982; 14(8):483-5. DOI: 10.1016/0022-2828(82)90156-0. View

4.
Corbalan R, Verrier R, LOWN B . Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release. Am Heart J. 1976; 92(2):223-30. DOI: 10.1016/s0002-8703(76)80258-x. View

5.
Clusin W, Bristow M, Baim D, Schroeder J, Jaillon P, Brett P . The effects of diltiazem and reduced serum ionized calcium on ischemic ventricular fibrillation in the dog. Circ Res. 1982; 50(4):518-26. DOI: 10.1161/01.res.50.4.518. View